Related Experiment Video
Updated: Jun 28, 2026
06:48
CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
Study of interaction between Smad7 and DNA by single-molecule force spectroscopy
Xiaoli Shi1, Feng Chen, Junping Yu
1Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructures and Nanotechnology, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Biochemical and Biophysical Research Communications
|November 11, 2008
Summary
Smad7, a TGF-beta pathway antagonist, binds DNA elements. Its MH2 domain shows higher affinity, while the N-terminal domain inhibits DNA binding, revealing unique specificity compared to other Smads.
Area of Science:
- Molecular Biology
- Cell Signaling
Background:
- Smad7 antagonizes the TGF-beta signaling pathway.
- Understanding Smad7's inhibitory mechanism is crucial.
- Previous work indicated Smad7 binds DNA elements with CAGA boxes in the nucleus.
Purpose of the Study:
- To investigate the DNA-binding properties of Smad7 using single-molecule force spectroscopy.
- To elucidate the specific DNA-binding characteristics and domain contributions of Smad7.
Main Methods:
- Single-molecule force spectroscopy (SMFS).
- Analysis of Smad7 binding to various DNA oligonucleotides, including wild-type and mutant activin responsive elements (ARE) and PAI-1 promoter sequences.
Main Results:
- Smad7 exhibited comparable DNA-binding strength to Smad4 for CAGA-containing ARE and PAI-1 promoter sequences.
- Smad7 demonstrated binding to a mutant ARE with a substituted CAGA sequence, suggesting distinct DNA-binding specificity.
- The MH2 domain of Smad7 displayed higher DNA-binding affinity than full-length Smad7.
- The N-terminal domain of Smad7 showed an inhibitory effect on DNA binding.
Conclusions:
- Smad7 possesses unique DNA-binding properties distinct from other Smads.
- The MH2 domain is critical for Smad7's DNA interaction, while the N-terminal domain modulates this binding.
